Efforts include a $12 million investment for state and local law enforcement, restructuring the DEA’s field division, establishing a DEA field division in Louisville, Ky., and requiring the offices of federal prosecutors to designate a coordinator to develop customized anti-opioid strategies.
“The current Louisville district office will now be the 22nd DEA Field Division, with about 90 special agents and 130 task force officers,” Mr. Sessions said, according to CBS News. “This field division will cover West Virginia, Kentucky and Tennessee. These areas covered by this new division face similar drug threats, enabling this division to better focus on those threats.”
During the press conference, Mr. Sessions also said President Donald Trump asked White House Councilor Kellyanne Conway to lead the administration’s efforts to address the opioid epidemic. The attorney general described Ms. Conway as “exceedingly talented” and said she “understands messaging,” according to CBS News.
More articles on opioids:
DEA mandates 20% reduction in opioid manufacturing for 2018
1 in 6 ER visits in Q2 were opioid related
Study: 61% of opioid overdoses occur among chronic pain patients
Becker’s 3rd Annual Fall Chief Pharmacy Officer Summit is the top tier event that the people leading the future of pharmacy convene. This 3-day event is built specifically for Chief Pharmacy Officers and senior pharmacy leaders. The sessions examine the workforce, financial and clinical priorities shaping pharmacy today. Becker’s is where candid discussions flourish and new ideas thrive. Becker's 3rd Annual Fall Chief Pharmacy Officer Summit
